Status:
RECRUITING
Nausea Induced by Radiation of the Dorsal Vagal Complex for Benign Brain Tumors (NausiCAA)
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Benign Brain Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Patients irradiated to the brain frequently experience nausea. The dorsal vagal complex (DVC) area is a specific brainstem zone and has been identified as likely responsible for nausea. Existing clini...
Detailed Description
Patients irradiated to the brain frequently experience nausea. The dorsal vagal complex (DVC) area is a specific brainstem zone and has been identified as likely responsible for nausea. Existing clini...
Eligibility Criteria
Inclusion
- More than 18 years old
- With benign brain tumor
- Irradiated with conventional fractionation (1,8-2Gy/fraction)
Exclusion
- History of brain radiation
- History of head and neck radiation
- Demencia
- Concurrent chemotherapy
- Nausea at the time of inclusion
- Anti-nausea treatment : corticosteroids, metoclopramide, setrons, other
Key Trial Info
Start Date :
May 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06506578
Start Date
May 20 2022
End Date
June 1 2026
Last Update
July 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux, Service de Radiothérapie
Bordeaux, France
2
Hospices Civils de Lyon, Service d'Oncologie Radiothérapie - Hôpital Neurologique
Lyon, France
3
Institut de cancérologie Strasbourg Europe (ICANS), Service d'Oncologie Radiothérapie
Strasbourg, France